rss
J Neurol Neurosurg Psychiatry 2009;80:196-200 doi:10.1136/jnnp.2008.151860
  • Research paper

Clinical prediction of postoperative seizure control: structural, functional findings and disease histories

  1. H Stefan1,
  2. M Hildebrandt3,
  3. F Kerling1,
  4. B S Kasper1,
  5. T Hammen1,
  6. A Dörfler4,
  7. D Weigel2,
  8. M Buchfelder2,
  9. I Blümcke3,
  10. E Pauli1
  1. 1
    Epilepsy Centre, Department of Neurology, University Hospital Erlangen, Erlangen, Germany
  2. 2
    Department of Neurosurgery, University Hospital Erlangen, Erlangen, Germany
  3. 3
    Department of Neuropathology, University Hospital Erlangen, Erlangen, Germany
  4. 4
    Department of Neuroradiology, University Hospital Erlangen, Erlangen, Germany
  1. Professor H Stefan, Epilepsy Centre, University Hospital Erlangen, Schwabachanalage 6, 91054 Erlangen, Germany; Hermann.stefan{at}uk-erlangen.de
  • Received 14 April 2008
  • Revised 8 July 2008
  • Accepted 8 July 2008
  • Published Online First 6 October 2008

Abstract

Objective: Mesial temporal lobe epilepsy (MTLE) constitutes a heterogenic entity with different clinical histories, pathomorphological hippocampal findings and varying postoperative outcome.

Method: 64 patients with MTLE, scheduled for hippocampal resection, were included. Initial precipitating injuries (IPI), structural and functional findings and neuropathological classification of hippocampal specimens were related to prediction of surgical outcome.

Results: Patients with severe hippocampal sclerosis (mesial temporal sclerosis (MTS) type 1b) became completely seizure free (80% Engel Ia) significantly more often compared with approximately 40% of seizure freedom in other types of MTS or in patients without hippocampal cell loss (non-MTS), irrespective of the extent of hippocampal resection. Age at IPI was found to be related to MTS variants (p<0.01) and significantly correlated with cell loss in the CA1 sector and the dentate gyrus (p<0.05). Presurgical MRI discriminated between MTS and non-MTS, but did not discriminate between different MTS subtypes. The most reliable predictors of MTS type 1b were the Wada memory scores combined with interictal and ictal EEG.

Conclusions: A particular cohort of MTLE patients benefit most from surgical treatment. These patients are clinically best recognised as presenting with (1) very early IPI; (2) a silent period of about 5 years; (3) unequivocal unilateral EEG localisation; (4) MRI signs of MTS; and (5) Wada Test indicates contralateral memory compensation and ipsilateral reduced memory capacity. MTS type 1b, characterised by severe cell loss in all hippocampal subfields including the dentate gyrus, and associated with optimal postoperative seizure control, was preoperatively clinically best differentiated from other MTS types by the Wada Memory Test.

Footnotes

  • Competing interests: None.

  • Ethics approval: Ethics approval was obtained.

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest neurology and neurosurgery jobs